No Prescription |
 |
 | ||
|
Acyclovir DT Generic Zovirax |
|
| ||
No Prescription » Prescription Drugs 1 » Acyclovir DT Generic Zovirax Acyclovir is used to treat infections caused by certain types of viruses. It treats cold sores around the mouth (caused by herpes simplex) shingles (caused by herpes zoster) and chickenpox.This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks acyclovir is used to help reduce the number of future episodes.Acyclovir is an antiviral drug. However it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster keeps new sores from forming and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition in people with a weakened immune system acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. Buy Acyclovir DT Generic Zovirax and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Acyclovir DT Generic Zovirax: Product Type: Prescription Drugs 1 Acyclovir DT (Generic Zovirax Aciclovir) Acyclovir DT (Generic Zovirax Aciclovir) Generic Zovirax Aciclovir 800mg 400mg 50 Tabs 100(2 x 50 Tablets) Generic Zovirax Aciclovir Acyclovir DT
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
